Xenon Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.82 |
Market Cap |
$261.63 M |
Shares Outstanding |
25.75 M |
Public Float |
22.79 M |
Address |
3650 Gilmore Way Burnaby British Columbia V5G 4W8 Canada |
Employees | - |
Website | http://www.xenon-pharma.com |
Updated | 07/08/2019 |
Xenon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in discovering and developing a pipeline of differentiated therapeutics. It has built a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. |